CS logo
small CS logo
Onkologische Schwerpunktpraxis

Heilbronn, Germany
Oncologist in Heilbronn, Baden-Württemberg
Allee 40, 74072 Heilbronn

About Onkologische Schwerpunktpraxis


"Wir heißen Sie herzlich willkommen in unserer Onkologischen Schwerpunktpraxis in Heilbronn. Es ist unser Anliegen, unsere Patienten bestmöglich zu beraten und zu behandeln. Wir möchten, dass Sie sich bei uns wohlfühlen und bieten Ihnen stets individuelle Beratung. Zentral gelegen in der Allee 40, mitten im Herzen von Heilbronn betreut Sie unser freundliches Praxisteam jederzeit gerne und stets auf höchstem Niveau. Auf unserer Internetpräsenz möchten wir uns und unsere Leistungen gerne vorstellen und Sie informieren. Gerne steht Ihnen unser freundliches und kompetentes Team persönlich wie auch telefonisch für Ihre Fragen zur Verfügung."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Onkologische Schwerpunktpraxis


During the past decade, Onkologische Schwerpunktpraxis conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Onkologische Schwerpunktpraxis


According to Clinical.Site data, the most researched conditions in "Onkologische Schwerpunktpraxis" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "BCR-ABL1-Negative Myeloid Neoplasms" (1 trials), "Multiple Myeloma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Onkologische Schwerpunktpraxis" in a lesser frequency.

Clinical Trials Intervention Types at Onkologische Schwerpunktpraxis


Most popular intervention types in "Onkologische Schwerpunktpraxis" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (3 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Pemetrexed" (2 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Onkologische Schwerpunktpraxis


The vast majority of trials in "Onkologische Schwerpunktpraxis" are 6 trials for "All" genders.

Clinical Trials Status at Onkologische Schwerpunktpraxis


Currently, there are NaN active trials in "Onkologische Schwerpunktpraxis". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Onkologische Schwerpunktpraxis, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Onkologische Schwerpunktpraxis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".